358 



PROTEIN 



split products 



'thyrotoxicon' from ice cream 



and milk, 57 

 therapy, effects of foreign 



protein, 13, 100 

 in acute infections, 100; in 



infectious diseases (typhoid), 



mode of action, 71 

 intravenous foreign protein in 



neurosyphilis, ^4-31 

 lipo-protein- nucleic acid complex 



(reticulose) in therapy of 



radiation injury, 752 

 nonspecific, actions and appli- 

 cations, 138 

 avoidance and 



palliation, 115 

 effect on autonomic 



nervous system, 129 



history reviewed, 226 



•in ocular disease, 



135, 326 



-in rheumatism, I9I 

 -resistance, 101, 102 

 -of chancroid, 1^2 

 of stomach and 



duodenal -ulcers, 113 

 reactions, 101,110 



PROTEOSE: See also Blood, 



temperature regulation after intra- 

 venous in j . , 10^4- 



PURIKE, metabolism, influence of 

 toxic substances on, 125 

 toxicity, associated with 



specific antigen of type Z 

 Sh . paradysenteriae , ^l8 



PURPURA 



meningococcic, experimental 



study in relation to Shwartz- 

 man phenomenon, 475 



PURILENCE: See: Pus, Staphylococci; 

 adrenal cortex extract as pro- 

 tection against, I89 



PUS, sterile, leukocytosis induced 

 in hypertensive dogs by, kOf 



PUTREFACTION, a product of tissue 

 destruction produces fever, 1 



PYOCYANASE, bactericidal soln. 

 from, 159 



PYRESE, and antipyrese, research, 

 16 



'PYRETAMIHE' of Russo, elimination 

 of histidine and total nit- 

 rogen during fever, klS 



'PYREXIN" See Paratyphoid, vaccine; 

 typhoid, vaccine 



PROTOPLASM, bacterial, partial toxin 

 in, 50 



PSEUDOGLOBULIN, in blood, See Blood, 

 globulin 



PSEUDOMOJIAS aeruginosa; See Bacteria, 

 Pseudomonas aeruginosa ; 

 Pyocyanase 

 scissa and ureae ; See Bacteria, 

 Pseudomonas 



PSEUDOTUBERCULOSIS, hacilli: See 

 Bacteria, Corynebacteriiim 



PSORIASIS, therapy with pyrifer, 

 171, 178 

 therapy xd.th typhoid vaccine, 

 95 



PYRIFER: See also: Fever, thera- 

 peutic 



antigenic characteristics, 680 



antitoxic quality of blood 

 reduced by, 268 



dosage, 260 



effects of, focal pain produced, 

 useful as diagnostic aid, 766; 

 glutathione and ergothionine 

 increased, 207; globulin- 

 albumin alterations in serum, 

 308; morphologic alterations 

 in plasma cells, 5l4 



effects on plasma barriers, 262; 

 neurologic syndromes, 767; 

 leukocytes and temperature 

 variations, 712 



preparation, character, 26O; 

 produced by Rosenberg, 

 Freiburg, 163 



